Compound Detail
CHEMBL5399420
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5399420 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QGGLESNNYLSYEA-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
392.5
MW (Da)
1.94
ALogP
7
HBA
3
HBD
102.1
PSA (Ų)
0.59
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.14
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 8.14 | 8.14 | 7.3 | 1 |
| Cyclin-dependent kinase 6 CHEMBL2508 | IC50 | 7.84 | 7.84 | 14.3 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Receptor-type tyrosine-protein kinase FLT3 | IC50 | = | 7.29 | nM | 8.14 | Inhibition of human FLT3 using EAIYAAPFAKKK and [gamma-33P]-ATP as substrate pre... | 37163951 |
| Cyclin-dependent kinase 6 | IC50 | = | 14.33 | nM | 7.84 | Inhibition of human CDK6 pretreated for 20 mins followed by [gamma-33P]-ATP addi... | 37163951 |
| Cyclin-dependent kinase 2 | IC50 | = | 23.03 | nM | 7.64 | Inhibition of human CDK2 pretreated for 20 mins followed by [gamma-33P]-ATP addi... | 37163951 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37163951 | 10.1016/j.ejmech.2023.115448 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 37163951 | 10.1016/j.ejmech.2023.115448 | Cyclin-dependent kinase 2 | 1 |
| 37163951 | 10.1016/j.ejmech.2023.115448 | Cyclin-dependent kinase 6 | 1 |
Data from ChEMBL 36 via Core Engine